Radiation Medicine and Protection (Mar 2022)

Salicylic acid sensitizes cervical cancer cells to radiotherapy by activating AMPK/TSC2/mTOR pathway

  • Shun Lu,
  • Wenjing Ye,
  • Jie Zhou,
  • Guangming Yi,
  • Jianming Huang,
  • Siyao Deng,
  • Minglun Li,
  • Yimin Li,
  • Yanqiong Song,
  • Jiayu Zhang,
  • Lichun Wei,
  • Guiquan Zhu,
  • Jinyi Lang

Journal volume & issue
Vol. 3, no. 1
pp. 9 – 15

Abstract

Read online

Objective: To investigate the radio-sensitizing effect of salicylic acid (SA) on human cervical cancer cells and its potential molecular mechanism. Methods: Cervical cancer cells were treated with SA and ionizing radiation. The expression of γ-H2AX was evaluated by immunofluorescence (IF) assay. Cell cycle and apoptosis were analyzed by flow cytometry. Western blot was performed to detect the protein level of AMPK/TSC2/mTOR pathway. Results: SA inhibited basal proliferation of cervical cancer cells in a dose and time dependent manner. In addition, SA increased radiation-induced DNA damage, promoted apoptosis, triggered a redistribution of cell cycle from G2-M phase to G1-S phase of cervical cancer cells, and hence increased cell sensitivity to radiation. Moreover, SA treatment elevated the expression levels of p-AMPKα(t ​= ​3.996, P ​< ​0.05) and p-TSC2(t ​= ​5.308, P ​< ​0.05), whereas the level of p-mTOR (t ​= ​10.160, P ​< ​0.05) was significantly decreased. Conclusion: SA enhances the radiosensitivity of cervical cancer cells by targeting AMPK/TSC2/mTOR signaling pathway, and might serve as a promising therapeutic strategy to improve the efficacy of radiotherapy for cervical cancer.

Keywords